Pomanda estimates the enterprise value of ELYSIUM NEUROLOGICAL SERVICES (BADBY) LIMITED at £12.4m based on a Turnover of £20.6m and 0.6x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ELYSIUM NEUROLOGICAL SERVICES (BADBY) LIMITED at £919.7k based on an EBITDA of £204k and a 4.51x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ELYSIUM NEUROLOGICAL SERVICES (BADBY) LIMITED at £0 based on Net Assets of £-11.4m and 2.48x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Elysium Neurological Services (badby) Limited is a live company located in hertfordshire, WD6 1JN with a Companies House number of 05558328. It operates in the medical nursing home activities sector, SIC Code 86102. Founded in September 2005, it's largest shareholder is
elysium neurological services limited
with a 100% stake. Elysium Neurological Services (badby) Limited is a mature,
large sized company, Pomanda has estimated its turnover at
£20.6m with
healthy
growth in recent years.
Elysium Neurological Services (badby) Limited Health Check
Pomanda's financial health check has awarded Elysium Neurological Services (Badby) Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
Health Rating3out of 5
5 Strong
1 Regular
5 Weak
Size
annual sales of £20.6m, make it larger than the average company (£4.6m)
Elysium Neurological Services (Badby) Limited's latest turnover from June 2024 is £20.6 million and the company has net assets of -£11.4 million. According to their latest financial statements, Elysium Neurological Services (Badby) Limited has 457 employees and maintains cash reserves of £68 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jun 2024
Jun 2023
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Turnover
20,573,000
27,231,000
14,346,000
11,698,000
8,446,000
7,353,000
7,283,000
6,461,000
6,456,259
5,683,000
4,837,000
4,414,000
3,329,000
1,583,779
Other Income Or Grants
Cost Of Sales
16,501,000
23,279,000
12,016,000
10,387,000
7,120,000
6,648,000
6,160,000
3,850,000
3,735,110
2,749,000
2,541,000
2,494,000
2,435,000
1,649,629
Gross Profit
4,072,000
3,952,000
2,330,000
1,311,000
1,326,000
705,000
1,123,000
2,611,000
2,721,149
2,934,000
2,296,000
1,920,000
894,000
-65,850
Admin Expenses
4,506,000
6,533,000
3,396,000
2,962,000
2,936,000
2,847,000
2,957,000
2,572,000
2,221,135
2,056,000
1,910,000
1,563,000
1,008,000
1,127,570
1,855,811
Operating Profit
-434,000
-2,581,000
-1,066,000
-1,651,000
-1,610,000
-2,142,000
-1,834,000
39,000
500,014
878,000
386,000
357,000
-114,000
-1,193,420
-1,855,811
Interest Payable
1,000
1,000
1,000
289,000
345,000
765,256
Interest Receivable
269
Pre-Tax Profit
-434,000
-2,581,000
-1,066,000
-1,651,000
-1,610,000
-2,142,000
-1,835,000
39,000
500,014
877,000
385,000
68,000
-459,000
-1,958,676
-1,855,542
Tax
24,000
-38,000
-36,000
-11,000
-14,000
-8,000
53,000
Profit After Tax
-410,000
-2,619,000
-1,102,000
-1,662,000
-1,624,000
-2,150,000
-1,782,000
39,000
500,014
877,000
385,000
68,000
-459,000
-1,958,676
-1,855,542
Dividends Paid
Retained Profit
-410,000
-2,619,000
-1,102,000
-1,662,000
-1,624,000
-2,150,000
-1,782,000
39,000
500,014
877,000
385,000
68,000
-459,000
-1,958,676
-1,855,542
Employee Costs
14,158,000
17,061,000
9,479,000
8,148,000
5,189,000
4,683,211
3,730,096
5,093,040
2,407,476
2,533,000
2,395,000
2,390,000
2,378,000
1,783,554
Number Of Employees
457
397
365
334
184
181
153
235
137
175
159
160
145
87
EBITDA*
204,000
-1,675,000
-532,000
-1,301,000
-1,395,000
-1,964,000
-1,743,000
102,000
540,409
901,000
399,000
6,647,000
255,000
-804,502
-1,809,998
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024
Jun 2023
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Tangible Assets
5,846,000
6,165,000
6,497,000
6,577,000
1,256,000
1,142,000
633,000
367,000
242,104
157,000
71,000
28,000
15,275,000
15,589,199
15,842,373
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
5,846,000
6,165,000
6,497,000
6,577,000
1,256,000
1,142,000
633,000
367,000
242,104
157,000
71,000
28,000
15,275,000
15,589,199
15,842,373
Stock & work in progress
25,000
24,000
24,000
13,000
10,000
9,000
8,000
Trade Debtors
32,000
32,000
66,000
908,000
579,000
383,000
2,003,000
363,000
444,317
672,000
564,000
348,000
110,000
125,221
53,798
Group Debtors
1,662,000
452,532
80,000
71,000
52,000
13,707
Misc Debtors
857,000
417,000
270,000
283,000
223,000
117,000
107,000
148,000
465,398
456,000
409,000
477,000
53,000
45,369
Cash
68,000
4,000
217,000
565,000
71,000
299,000
1,099,000
201,000
203,636
105,000
148,000
115,000
887
107,490
misc current assets
total current assets
982,000
477,000
577,000
1,769,000
883,000
808,000
3,217,000
2,374,000
1,565,883
1,313,000
1,192,000
992,000
163,000
185,184
161,288
total assets
6,828,000
6,642,000
7,074,000
8,346,000
2,139,000
1,950,000
3,850,000
2,741,000
1,807,987
1,470,000
1,263,000
1,020,000
15,438,000
15,774,383
16,003,661
Bank overdraft
27,000
257,000
201,365
Bank loan
9,693,000
141,802
Trade Creditors
138,000
174,000
159,000
345,000
361,018
160,000
106,000
152,000
104,000
221,044
9,061,580
Group/Directors Accounts
17,661,000
16,586,000
15,081,000
15,214,000
7,163,000
5,349,000
4,982,000
1,810,000
406,000
109,478
other short term finances
hp & lease commitments
14,000
3,723
other current liabilities
513,000
941,000
324,000
377,000
421,000
326,000
518,000
613,000
1,513,130
1,877,000
2,601,000
2,697,000
690,000
200,271
total current liabilities
18,174,000
17,554,000
15,405,000
15,591,000
7,722,000
5,849,000
5,659,000
2,768,000
1,874,148
2,037,000
2,707,000
2,849,000
11,164,000
877,683
9,061,580
loans
10,149,272
hp & lease commitments
14,023
Accruals and Deferred Income
other liabilities
250,000
provisions
30,000
54,000
16,000
60,000
total long term liabilities
30,000
54,000
16,000
60,000
10,163,295
250,000
total liabilities
18,204,000
17,608,000
15,421,000
15,591,000
7,722,000
5,909,000
5,659,000
2,768,000
1,874,148
2,037,000
2,707,000
2,849,000
11,164,000
11,040,978
9,311,580
net assets
-11,376,000
-10,966,000
-8,347,000
-7,245,000
-5,583,000
-3,959,000
-1,809,000
-27,000
-66,161
-567,000
-1,444,000
-1,829,000
4,274,000
4,733,405
6,692,081
total shareholders funds
-11,376,000
-10,966,000
-8,347,000
-7,245,000
-5,583,000
-3,959,000
-1,809,000
-27,000
-66,161
-567,000
-1,444,000
-1,829,000
4,274,000
4,733,405
6,692,081
Jun 2024
Jun 2023
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Operating Activities
Operating Profit
-434,000
-2,581,000
-1,066,000
-1,651,000
-1,610,000
-2,142,000
-1,834,000
39,000
500,014
878,000
386,000
357,000
-114,000
-1,193,420
-1,855,811
Depreciation
638,000
906,000
534,000
350,000
215,000
178,000
91,000
63,000
40,395
23,000
13,000
6,290,000
369,000
388,918
45,813
Amortisation
Tax
24,000
-38,000
-36,000
-11,000
-14,000
-8,000
53,000
Stock
1,000
24,000
11,000
3,000
1,000
1,000
8,000
Debtors
440,000
449,000
-855,000
389,000
302,000
-1,610,000
-63,000
810,753
154,247
164,000
167,000
714,000
-21,297
130,499
53,798
Creditors
-138,000
-36,000
15,000
-186,000
-16,018
201,018
54,000
-46,000
48,000
-117,044
-8,840,536
9,061,580
Accruals and Deferred Income
-428,000
941,000
-53,000
-44,000
95,000
-192,000
-95,000
-900,130
-363,870
-724,000
-96,000
2,007,000
489,729
200,271
Deferred Taxes & Provisions
-24,000
54,000
16,000
-60,000
60,000
Cash flow from operations
-665,000
-1,191,000
239,000
-1,886,000
-1,713,000
-480,000
-1,916,000
-1,624,901
223,310
67,000
90,000
7,988,000
648,982
-9,575,266
7,197,784
Investing Activities
capital expenditure
-319,000
-7,071,000
-454,000
-5,671,000
-329,000
-687,000
-357,000
-187,896
-125,499
-109,000
-56,000
8,957,000
-54,801
-15,888,186
Change in Investments
cash flow from investments
-319,000
-7,071,000
-454,000
-5,671,000
-329,000
-687,000
-357,000
-187,896
-125,499
-109,000
-56,000
8,957,000
-54,801
-15,888,186
Financing Activities
Bank loans
-9,693,000
9,551,198
141,802
Group/Directors Accounts
1,075,000
16,586,000
-133,000
8,051,000
1,814,000
367,000
3,172,000
1,810,000
-406,000
296,522
109,478
Other Short Term Loans
Long term loans
-10,149,272
10,149,272
Hire Purchase and Lease Commitments
-14,000
-3,746
17,746
other long term liabilities
-250,000
250,000
share issue
-8,347,000
161
825
-6,171,000
-405
8,547,623
interest
-1,000
-1,000
-1,000
-289,000
-345,000
-765,256
269
cash flow from financing
1,075,000
8,239,000
-133,000
8,051,000
1,814,000
367,000
3,171,000
1,810,161
825
-1,000
-1,000
-16,573,000
-650,703
9,403,042
8,797,892
cash and cash equivalents
cash
64,000
4,000
-348,000
494,000
-228,000
-800,000
898,000
-2,636
98,636
-43,000
33,000
115,000
-887
-106,603
107,490
overdraft
-27,000
27,000
-257,000
55,635
201,365
change in cash
91,000
-23,000
-348,000
494,000
-228,000
-800,000
898,000
-2,636
98,636
-43,000
33,000
372,000
-56,522
-307,968
107,490
elysium neurological services (badby) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for elysium neurological services (badby) limited. Get real-time insights into elysium neurological services (badby) limited's credit score, group structure and payment trends.
Perform a competitor analysis for elysium neurological services (badby) limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other large companies, companies in WD6 area or any other competitors across 12 key performance metrics.
Elysium Neurological Services (Badby) Limited currently has 4 directors.
The longest serving directors include
Dr Quazi Haque (Apr 2017) and
Mrs Kathryn Murphy (Sep 2020).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 11 charges/mortgages relating to elysium neurological services (badby) limited. Currently there are 0 open charges and 11 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ELYSIUM NEUROLOGICAL SERVICES (BADBY) LIMITED. This can take several minutes, an email will notify you when this has completed.
elysium neurological services (badby) limitedCompanies House Filings - See Documents
